Postpartum Family Planning Service Through Enhanced Family Planning in Immunization Services
NCT ID: NCT01115361
Last Updated: 2012-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
800 participants
INTERVENTIONAL
2010-02-28
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postpartum Family Planning Program in Rwanda
NCT05056545
Utilizing All Health System Contacts to Offer Postpartum Family Planning (PPFP) in Ethiopia
NCT03585361
Increasing Family Planning Uptake Among Postpartum Women
NCT00949481
Testing a Modified Family Planning Intervention for Postpartum Women in Uganda
NCT04068870
Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization
NCT04780243
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To determine the effectiveness of an intervention, which is designed to increase contraceptive prevalence among postpartum women attending vaccination services who desire to either space or limit their pregnancies, thus reducing unmet contraceptive need in this population.
The Intervention:
A. Brief, concise messages conveyed to women during group education sessions regarding pregnancy risk, benefits of FP, and family planning options during the postpartum period.
B.IEC materials such as posters and brochures that deliver messages about the benefits of spacing pregnancies by at least 2 years, LAM, return to fecundity and pregnancy risk during the postpartum period and contraceptive options for postpartum women.
C.Use of a screening tool (Appendix A) to assess pregnancy risk for postpartum women coupled with a brief counseling message depending upon risk classification which includes referral to FP services for those currently or soon-to-be at-risk of pregnancy.
D.Convenient offer of FP services to women attending vaccination services for their infants either concurrently with vaccination services, or at the same facility and on the same day, but at a different time from vaccination services.
Study Design:
Experimental, two-group (intervention/control) pretest (pre-intervention) /posttest (post-intervention) design 12 month intervention period. A mid-course collection of process data will also be conducted at 6 months to assess the degree to which the intervention is being implemented as intended and to provide an opportunity for corrective action if needed.
Participants: Women attending vaccination services for their infants, and vaccination and FP providers
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PPFP in child immunization
Women attending immunization services for their infant will receive educational brochures, group education and individual counseling on the benefits of the health timing and spacing of births,, pregnancy risk and return to fertility during the extended postpartum period (12 months), and referral to family planning services for those who are interested.
Family planning for postpartum women
A.Group education sessions regarding pregnancy risk, benefits of FP, and family planning options during the postpartum period.
B. IEC materials that deliver messages about the benefits of spacing pregnancies by at least 2 years, LAM, return to fecundity and pregnancy risk during the postpartum period and contraceptive options for postpartum women.
C. Use of a screening tool to assess pregnancy risk for postpartum women coupled with a brief counseling message and referral to FP services.
D.Convenient offer of FP services to women attending vaccination services for their infants.
Control - Standard of care
The control arm will receive standard of care infant immunization services.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family planning for postpartum women
A.Group education sessions regarding pregnancy risk, benefits of FP, and family planning options during the postpartum period.
B. IEC materials that deliver messages about the benefits of spacing pregnancies by at least 2 years, LAM, return to fecundity and pregnancy risk during the postpartum period and contraceptive options for postpartum women.
C. Use of a screening tool to assess pregnancy risk for postpartum women coupled with a brief counseling message and referral to FP services.
D.Convenient offer of FP services to women attending vaccination services for their infants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adult women, aged 21 years and older, or married women ages 18 to 20 who have achieved legal majority status by emancipation due to marriage,
* bring their infants between the ages 6-12 months to immunization services at study sites
Providers:
* all health care providers who currently provide immunization services to infants and/or family planning services within the selected facilities.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Rwanda
OTHER_GOV
FHI 360
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa S Dulli, PhD, MHS
Role: PRINCIPAL_INVESTIGATOR
FHI 360
Steve Sortijas, MPH
Role: STUDY_DIRECTOR
FHI 360
Fidèle Ngabo, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Ministry of Health, Rwanda
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rwanda health care facilities
Kigali, , Rwanda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
890028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.